Y-mAbs Therapeutics Inc.

5.20
-0.36 (-6.47%)
At close: Mar 03, 2025, 3:59 PM
5.15
-0.85%
After-hours: Mar 03, 2025, 06:41 PM EST

Y-mAbs Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Cash & Equivalents 78.64M 105.76M 181.56M 114.63M 207.14M 147.84M 90.48M 16.88M
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 12.49M 5.68M 3.17M 3.29M 370K 187K 772K n/a
Receivables 22.45M 12.53M 7.71M n/a n/a n/a n/a n/a
Inventory 5.07M 6.7M 5.51M -800K n/a n/a n/a n/a
Other Current Assets 4.96M 5.45M 7.47M 7.73M 4.82M 3.69M 872K 386K
Total Current Assets 111.11M 130.45M 202.26M 122.36M 211.96M 151.53M 91.36M 17.26M
Property-Plant & Equipment 1.64M 2.34M 5.69M 6.39M 4.04M 205K n/a n/a
Goodwill & Intangibles 2.63M 2.99M 1.66M n/a n/a n/a n/a n/a
Total Long-Term Assets 16.76M 11.01M 10.52M 9.68M 4.41M 392K 772K n/a
Total Assets 127.87M 141.46M 212.78M 132.05M 216.37M 151.92M 92.13M 17.26M
Account Payables 6.06M 14.18M 13.55M 9.37M 8.52M 5.87M 5.91M 2.23M
Deferred Revenue n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 902K 1.74M 3.57M 3.93M 1.03M n/a n/a n/a
Other Current Liabilities 13.17M 12.37M 10.76M 6.23M 4.03M 3.25M 2.02M 748K
Total Current Liabilities 20.13M 28.28M 27.88M 19.54M 13.59M 9.12M 7.92M 2.98M
Long-Term Debt 517K 899K 1.85M 2.01M 1.71M n/a n/a n/a
Other Long-Term Liabilities 6.24M 3.05M 2.95M 4.66M 2.16M 2.27M 2.05M 2.23M
Total Long-Term Liabilities 6.76M 3.95M 4.8M 6.68M 3.88M 2.27M 2.05M 2.23M
Total Liabilities 26.88M 32.23M 32.68M 26.21M 17.46M 11.4M 9.97M 5.2M
Total Debt 1.42M 1.77M 3.63M 3.98M 2.23M n/a n/a n/a
Common Stock 4K 4K 4K 4K 4K 3K 3K 2K
Retained Earnings -457.47M -436.04M -340.48M -285.2M -165.86M -84.83M -41.56M -22.4M
Comprehensive Income 449K 1.33M 1.37M -526K 50K 7K -169K 30K
Shareholders Equity 100.98M 109.22M 180.11M 105.84M 198.9M 140.53M 82.15M 12.06M
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a